Company / Free Cash Flow
Immunome Inc. Free Cash Flow History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
-$200.6M
FY2025
5-year range
-$200.6M / -$8.4M
FY2021-FY2025
Trend
-2288.4%
vs FY2024
Sector context
#151 of 194
Health Care
What the data says
Free Cash Flow changed -2288% YoY in FY2025, a notable deviation from the 6-year average annual change of -391%.
Based on SEC 10-K filings.
-$201M in FY2025.
Declined from -$29M to -$201M over the past 2 years.
Health Care sector context is included.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 22% in Health CareTop 78% of 194This company -$200.6M Sector average $470.8M
▼
-142.6% below sector average
Key checks
Key Insights
- In FY2025, free cash flow decreased 2288.4% year-over-year.
- Ranks #151 out of 194 companies in the Health Care sector.
- Peak free cash flow was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score 4.19 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$200.6M | -2288.4% |
| FY2024 | -$8.4M | +71.0% |
| FY2023 | -$28.9M | +0.0% |
| FY2022 | -$28.9M | -58.1% |
| FY2021 | -$18.3M | -43.9% |
| FY2020 | -$12.7M | -29.4% |
| FY2019 | -$9.8M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026